Apogee secures $1.3B deal
Apogee Therapeutics secures financing from Blackstone, shares decline. Deal valued at $1.3 billion.
Apogee Therapeutics secures financing from Blackstone, shares decline.
Deal valued at $1.3 billion.
Apogee Therapeutics secures financing from Blackstone, shares decline. Deal valued at $1.3 billion.
Apogee Therapeutics secures financing from Blackstone, shares decline.
Deal valued at $1.3 billion.